Eurofarma Innovation and Growth Strategy

17 FINANCIAL HIGHLIGHTS Historical Net Revenue (R$ million) CAGR 23% 5,723 4,828 3,702 3,122 7,068 Adjusted EBITDA1 (R$ million) Net Income (R$ million) Net Debt/ EBITDA (x) 1,929 1,000 CAGR 26% +13% CAGR 28% 849 1,529 +28% +11% 3,852 1,178 1,178 3,423 912 923 761 580 491 483 434 368 0.35 eurofarma 0.67 0.47 1.00 0.87 0.90 0.05 2017 2018 2019 2020 2021 1H21 1H22 2017 2018 2019 2020 2021 1H21 1H22 2017 2018 2019 2020 2021 1H21 1H22 2017 2018 2019 2020 2021 1Q22 2Q22 Margin 24.4% 24.6% 24.4% 26.7% 27.3% 27.0% 30.6% 11.8% 13.3% 12.0% 14.8% 14.1% 12.7% 12.5% 1- Adjusted for R&D expenses

View entire presentation